SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Clinigence Holdings, Inc. (CLNH) trades at a trailing P/E of 0.2. Trailing earnings yield is 555.56%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.2); earnings yield beats bond yields (555.56%).
- Trailing Earnings Yield 555.56% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 77/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CLNH
Valuation Multiples
P/E (TTM)0.2
Forward P/EN/A
PEG Ratio0.00
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.04
EV/EBITDA0.0
Per Share Data
EPS (TTM)$36.49
Book Value / Share$0.00
Revenue / Share$177.10
FCF / Share$0.00
Yields & Fair Value
Earnings Yield555.56%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-12.50 |
$1.07M |
$-684K |
-64% |
| 2015 |
$1.35 |
$474.68K |
$83.81K |
17.7% |
| 2016 |
$-93.63 |
$0.00 |
$-7.43M |
- |
| 2017 |
$3.48 |
$23.17K |
$582.06K |
2512.6% |
| 2018 |
$-9.79 |
$60.22K |
$-2.81M |
-4672.6% |
| 2019 |
$-1.96 |
$1.37M |
$-7.12M |
-521% |
| 2020 |
$0.00 |
$1.59K |
$-5.65K |
-356.2% |
| 2021 |
$0.00 |
$18.79K |
$-13.67K |
-72.7% |
| 2024 |
$9.71 |
$479.95B |
$52.18B |
10.9% |
| 2025 |
$36.49 |
$875.26M |
$180.36M |
20.6% |
